NTRA - natera.com Sales Growth YoY (TTM)

Graphic logo of Natera Medical (NTRA)

The scalability of DNA algorithms reduces costs for Natera, Inc. (NTRA), increasing test margins. The revenue trend over four quarters year-over-year allows for an assessment of real commercial dynamics, where the value of 37.60 serves as the current indicator. The growth of Signatera in oncology and the recruitment of leading bioinformatics scientists create a foundation for expansion and the strengthening of positions within the reproductive sector.

Natera, Inc. - NTRA Sales Growth YoY (TTM) (period 02/11/2024 - 11/18/2026)

natera.com (NTRA) - metric breakdowns and financial figures

- share price and expert price forecast:
Fundamental company valuation:Natera Corp
Brand item of Natera, Inc.

Natera, Inc. (NTRA) status as a leading developer of high-precision prenatal tests translates into sustainable demand, which is reflected in the revenue dynamics. This relative sales growth over a 12-month period compared to the previous year measures the pace of business expansion via a TTM rolling window, allowing the investor to separate the long-term fundamental trend from short-term fluctuations and assess the company's real market expansion.